DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20170837

Cost variation analysis of antipsychotic drugs available in Indian market: an economic perspective

Nishita P. Shah, Aparna S. Chincholkar, Ranjit J. Wagh, Waseem A. Siddiqui

Abstract


Background: Pricing of drugs plays a very important role in a developing country like India especially in the management of chronic conditions. There exists a huge price variation among the different brands of the same drug. Hence this study was planned to find out variation in prices of antipsychotic drugs marketed in India. The objective was to compare the percentage price variation and cost ratio of various formulations of oral and parenteral antipsychotic drugs available in the Indian market.

Methods: Cost of oral and parenteral antipsychotic drugs available in the Indian market manufactured by different companies, in the same strength, number and dosage form was obtained from http://www.medguideindia.com. The percentage price variation and cost ratio of each formulation was calculated.

Results: Among the typical group of antipsychotic drugs, Tab Haloperidol 0.25mg shows maximum price variation of 650% and a cost ratio of 7.5 followed by Tab Trifluoperazine 1mg having a price variation of 555.5% and a cost ratio of 6.55. Among the atypical group of drugs, tab Risperidone 3mg shows a price variation of 2282.35% with a cost ratio of 23.82 followed by Tab Risperidone 4mg with a price variation of 1976.92 % and a cost ratio of 20.76.

Conclusions: There is a wide variation between the minimum and maximum cost among the different brands of the same drug in the same formulations. Combined efforts are needed from the regulatory authorities, pharmaceutical companies, physicians and pharmacist towards controlling the prices and attaining maximum economic benefits for the patient.


Keywords


Antipsychotic drugs, Branded generics, Cost variation, Pharmacoeconomics

Full Text:

PDF

References


Karve AV, Chattar KB. Cost Analysis Study of Oral Antihypertensive agents available in Indian market, IJBCP International Journal of Basic and Clinical Pharmacology. International Journal. 2014 May;3(3):479.

Date AP, Mahajan HM, Dashputra AV, Bhosale RR. Study of variation in price of various antidiabetic drugs available in Indian market. International Journal of Basic and Clinical Pharmacology. 2015;4(1):36-40.

Hussain S, Pharm M. Cost variation analysis of Oral Hypoglycaemic agents available in Indian market: An Economic Perspective. International Journal of Pharma Sciences and Research. 2015;6(5):913-8.

Kamath L, Satish GR. Cost variation analysis of antihypertensive drugs available in Indian market: An economic perspective. International Journal of Pharmaceutical Sciences and Research. 2016 May;7(5):2050.

Kulkarni U, Dalvi K, Moghe VV, Deshmukh YA. Pharmacoeconomics: An emerging branch in health sciences for decision making. African Journal of Pharmacy and Pharmacology. 2009 Aug 31;3(8):362-7.

Atal S, Deshmankar B, Nawaz SA. Cost analysis of commonly used drugs under price control in India: Assessing the effect of drug price control order on brand price variation. International Journal of Pharmacy and Pharmaceutical Sciences. 2016 Apr;8(4):315-21.

Compendium of notified ceiling prices of Schedule Drugs. National Pharmaceutical Pricing Authority 2015. Available from: http://www.nppaindia.nic.in/DPCO2013.pdf

Kumar V, Gupta NV, Kumar AK. A Comparison between old and latest systems in DPCO. Int J Pharm Pharm Sci. 2014;6:19-20.

Moncrieff J, Cohen D, Mason JP. The subjective experience of taking antipsychotic medication: a content analysis of Internet data. Acta Psychiatrica Scandinavica. 2009 Aug;120(2):102-11.

Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. Canadian Medical Association Journal. 2005 Jun;172(13):1703-11.

Harichandran DT, Viswanathan MT, Gangadhar R. Adverse drug reactions among hospitalized patients in Psychiatry Department in a Tertiary Care Hospital. Journal of Health Research and Reviews. 2016 May;3(2):77.

Shukla AK, Mehani R. Cost analysis of antiepileptic drugs available in India. International Journal of Basic and Clinical Pharmacology. 2016;5(4):1636-40.

Nallani VR. Cost analysis study of oral anti-diabetic drugs available in Indian Govt. Generic (Jan Aushadhi, Jeevandhara) drugs and brand drugs market in rural/urban area of Guntur, Andhrapradesh, India. Value in Health. 2015 Nov;18(7):A717.

Shrestha B. Cost analysis of oral antihypertensive agents available in Nepal. Journal of Institute of Medicine. 2015 Nov;38(2).

Jadhav NB, Bhosale MS, Adhav CV. Cost analysis study of oral antidiabetic drugs available in Indian market. International Journal of Medical Research and Health Sciences. 2013;1(2):63-9.